Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard L Bennett

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Biorxiv : the Preprint Server for Biology|November 28, 2024
Aberrant expression of histone H2B variants reshape chromatin and alter oncogenic gene expression programsWesley N Saintilnord, Youssef A Hegazy, Kristin Chesnutt, et al.
Nature Communications|November 29, 2023
HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasisMichael F Emmons, Richard L Bennett, Alberto Riva, et al.
Cancer Discovery|July 25, 2019
A Mutation in Histone H2B Represents a New Class of Oncogenic DriverRichard L Bennett, Aditya Bele, Eliza C Small, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
KDM6A Regulates Immune Response Genes in Multiple MyelomaDaphne Dupéré-Richer, Alberto Riva, Sayantan Maji, et al.
Blood|July 24, 2024
KDM6A regulates immune response genes in multiple myelomaDaphné Dupéré-Richer, Alberto Riva, Benjamin G Barwick, et al.
Blood|April 10, 2024
NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenomeAmin Sobh, Elena Encinas, Alisha Patel, et al.
Cancer Discovery|August 21, 2021
PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by <i>NSD2</i> Mutation in Pediatric Acute Lymphoblastic LeukemiaJianping Li, Julia Hlavka-Zhang, Jonathan H Shrimp, et al.
JCI Insight|April 25, 2023
First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survivalMaria V Guijarro, Patrick C Kellish, Peter E Dib, et al.
Cancer Research|February 9, 2026
A Multi-Step Immune-Competent Genetically Engineered Mouse Model Reveals Phenotypic Plasticity in Uveal MelanomaXiaonan Xu, Xiaoxian Liu, Vinesh Jarajapu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
DNMT3A Harboring Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication ForksKartika Venugopal, Yang Feng, Pawel Nowialis, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|November 28, 2024
Aberrant expression of histone H2B variants reshape chromatin and alter oncogenic gene expression programsWesley N Saintilnord, Youssef A Hegazy, Kristin Chesnutt, et al.
Nature Communications|November 29, 2023
HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasisMichael F Emmons, Richard L Bennett, Alberto Riva, et al.
Cancer Discovery|July 25, 2019
A Mutation in Histone H2B Represents a New Class of Oncogenic DriverRichard L Bennett, Aditya Bele, Eliza C Small, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
KDM6A Regulates Immune Response Genes in Multiple MyelomaDaphne Dupéré-Richer, Alberto Riva, Sayantan Maji, et al.
Blood|July 24, 2024
KDM6A regulates immune response genes in multiple myelomaDaphné Dupéré-Richer, Alberto Riva, Benjamin G Barwick, et al.
Blood|April 10, 2024
NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenomeAmin Sobh, Elena Encinas, Alisha Patel, et al.
Cancer Discovery|August 21, 2021
PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by <i>NSD2</i> Mutation in Pediatric Acute Lymphoblastic LeukemiaJianping Li, Julia Hlavka-Zhang, Jonathan H Shrimp, et al.
JCI Insight|April 25, 2023
First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survivalMaria V Guijarro, Patrick C Kellish, Peter E Dib, et al.
Cancer Research|February 9, 2026
A Multi-Step Immune-Competent Genetically Engineered Mouse Model Reveals Phenotypic Plasticity in Uveal MelanomaXiaonan Xu, Xiaoxian Liu, Vinesh Jarajapu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
DNMT3A Harboring Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication ForksKartika Venugopal, Yang Feng, Pawel Nowialis, et al.
Pageof 4